do glp 1 change your taste buds Frontiers As GLP-1 medications gain popularity,
Description
Learn who's a good candidate, what to expect during treatment, and more.
At the same time, payer policies often require discontinuation of GLP-1 therapy when a patients BMI drops below a set threshold, inadvertently triggering a frustrating cycle of weight loss and regainthe so-called yo-yo effect. This not only impacts ongoing adherence and persistence but also undermines the long-term cost-effectiveness of these therapies for healthcare systems
Recently, Eli Lilly introduced a promising new oral GLP-1 receptor agonist called orforglipron, which has significantly piqued my professional curiosity.
Christopher Chung
1 "Substantial and Durable glycemic control
